| Patents for C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394) |
|---|
| 04/23/2002 | US6376649 Methods for the synthesis of α- hydroxy-β-amino acid and amide derivatives |
| 04/23/2002 | US6376534 Guanidine compound; side effect reduction |
| 04/23/2002 | CA2004127C Novel aminobenzoates |
| 04/18/2002 | WO2002030877A1 Method for producing a disinfectant |
| 04/18/2002 | WO2002012166A3 Triamine derivative melanocortin receptor ligands and methods of using same |
| 04/17/2002 | EP1196378A1 Aminoguanidine bicarbonate with particular properties and method for making same |
| 04/11/2002 | WO2002028825A2 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 04/11/2002 | CA2423883A1 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 04/10/2002 | EP1194633A1 Agent for coloring fibers and method for temporarily coloring fibers |
| 04/10/2002 | EP1194401A1 Diacylhydrazine derivatives |
| 04/09/2002 | US6369110 Substituted guanidine derivatives and process for producing the same |
| 04/04/2002 | WO2000063193A9 Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them |
| 04/04/2002 | US20020040162 Contrast media for angiography |
| 04/03/2002 | EP1192145A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
| 04/03/2002 | EP1191934A1 Il-8 receptor antagonists |
| 04/02/2002 | US6365167 Treating wounds, lesions, lacerations, burns and ulcers in humans and animals by administering composition of reaction product of arginine and p-aminobenzoic acid |
| 03/28/2002 | US20020037854 Use of at least one no synthase inhibitor for treating sensitive skin |
| 03/27/2002 | EP1189862A1 Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates |
| 03/27/2002 | EP1189612A1 Vla-4 inhibitor compounds |
| 03/26/2002 | CA2176670C 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics |
| 03/21/2002 | WO2002022626A1 Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds |
| 03/21/2002 | WO2002022553A2 Non-natural basic amino acids, their preparation and use |
| 03/21/2002 | WO2002022135A1 Creatine ester pronutrient compounds and formulations |
| 03/21/2002 | CA2459599A1 Non-natural basic amino acids, their preparation and use |
| 03/20/2002 | EP1187833A1 Method of producing nitroguanidine- and nitroenamine derivatives |
| 03/20/2002 | EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/19/2002 | US6358922 Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides |
| 03/19/2002 | US6358696 Methods of treatment of eye trauma and disorders |
| 03/14/2002 | WO2002020475A2 Inhibitors of serine protease activity of matriptase or mtsp1 |
| 03/14/2002 | CA2422157A1 Inhibitors of serine protease activity of matriptase or mtsp1 |
| 03/13/2002 | EP1185270A1 Il-8 receptor antagonists |
| 03/13/2002 | EP0975219B1 Fungicide active substance combinations |
| 03/13/2002 | CN1080720C 噻唑衍生物 Thiazole derivatives |
| 03/07/2002 | WO2002018327A2 Guanidinobenzamides as mc4-r agonists |
| 03/07/2002 | US20020028836 Potassium channel openers |
| 03/06/2002 | CN1080257C Guanidine derivatives |
| 03/05/2002 | US6353027 Enantiomorphic amine derivatives for treatment of diabetes |
| 02/28/2002 | WO2002016318A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 02/28/2002 | CA2417507A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 02/26/2002 | CA2081605C Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent |
| 02/21/2002 | WO2002014329A1 Compositions with vascular damaging activity |
| 02/21/2002 | US20020022596 Novel malonic acid derivatives, processes for their preparation their use and pharmaceutical compositions containing them |
| 02/20/2002 | EP1180369A1 MEDICINAL COMPOSITIONS CONTAINING ANTI-Fas ANTIBODY |
| 02/20/2002 | EP1180025A1 Il-8 receptor antagonists |
| 02/19/2002 | US6348529 Guanidine compound and heat sensitive recording material |
| 02/19/2002 | US6348207 Exposing biologically active agent to complexing perturbant to reversibly transform biologically active agent to intermediate state and form orally deliverable supramolecular complex, orally administering complex to subject |
| 02/14/2002 | WO2002012177A1 Composition of metformin with succinic acid or salts thereof and method for treating diabetes |
| 02/14/2002 | WO2002012168A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 02/14/2002 | WO2002012166A2 Triamine derivative melanocortin receptor ligands and methods of using same |
| 02/14/2002 | CA2415467A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 02/13/2002 | EP1179529A1 Novel hydroxamic acid derivatives |
| 02/12/2002 | US6346527 Guanidine derivatives |
| 02/07/2002 | WO2001079359A3 Guanidinium and isothiouronium compounds and methods for their use |
| 02/07/2002 | US20020016350 Useful in treatment of diseases or conditions associated with erythropoietin receptor |
| 02/06/2002 | EP1177169A1 6- [(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof |
| 02/06/2002 | EP0891325B1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists |
| 02/06/2002 | CN1078886C Inhibitor of inhibiting generation of beta-amyloid |
| 02/05/2002 | US6344562 Thiazole derivatives |
| 02/05/2002 | US6344486 Anticoagulants |
| 02/05/2002 | US6344466 Antithrombotic activity, use in inhibiting loss of blood platelets, inhibiting formation of blood platelet aggregates, inhibiting formation of fibrin, anticoagulants |
| 02/05/2002 | US6344444 Arginine-silicate-inositol complex and use thereof |
| 02/05/2002 | US6344439 Agents for promoting bone formation |
| 01/31/2002 | WO2002008175A2 Arginine saccharate and use thereof |
| 01/30/2002 | EP1175217A2 (s)-benzoquinolizine carboxylic acids and their use as antibacterial agents |
| 01/30/2002 | CN1333747A ((Aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy |
| 01/30/2002 | CN1078588C The preparation of substituted guanidine derivatives |
| 01/24/2002 | US20020010316 Thiazole derivatives |
| 01/24/2002 | US20020010195 Mitochondria protecting agents for treating mitochondria associated diseases |
| 01/23/2002 | CN1332734A Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity |
| 01/23/2002 | CN1332723A Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 01/17/2002 | WO2002004406A2 9-substituted minocycline compounds |
| 01/17/2002 | WO2001055107A3 Aromatic amines and amides acting on the melanocortin receptors |
| 01/17/2002 | US20020007073 Capable of producing complexes with polynucleotides (DNA, RNA, antisense oligonucleotides, ribozymes); suitable as vectors for transfection |
| 01/17/2002 | US20020006957 Method for the synthesis of compounds of formula I and their uses thereof |
| 01/10/2002 | WO2001046129A3 Method for producing nitroguanidine |
| 01/10/2002 | WO2001042192A3 Vla-4 integrin antagonists |
| 01/10/2002 | US20020004522 Nervous system disorders |
| 01/10/2002 | US20020004219 Diagnosis of bacteria infections |
| 01/09/2002 | CN1077569C The preparatin of substituted guanidine derivative |
| 01/08/2002 | US6337350 Inhibitors of formation of advanced glycation endproducts (AGEs) |
| 01/03/2002 | WO2002000614A1 Aryl compounds, their preparation and their use in therapy |
| 01/03/2002 | US20020001591 Compositions for the delivery of antigens |
| 01/03/2002 | DE10030891A1 New 3,4-dihydroxybenzyl-substituted carbonic acid derivatives are antioxidants and radical scavengers useful e.g. for preventing skin aging or protecting cosmetic, dermatological or foodstuff compositions against oxidation |
| 01/02/2002 | EP1165064A2 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 12/27/2001 | WO2001098235A2 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants |
| 12/27/2001 | WO2001028979A3 Inhibitors of neuraminidases |
| 12/27/2001 | US20010056185 C3A receptor ligands |
| 12/26/2001 | CN1328542A Method of producing N-alkyl-N'-nitroguanidine |
| 12/26/2001 | CN1328452A Use of benzoylguanidines for treatment of non-insulin-dependent diabetes mellitus |
| 12/20/2001 | WO2001096281A1 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same |
| 12/20/2001 | US20010053855 Modified alkoxycarbonyloxypyridine as oligonucleotide blocking agent |
| 12/20/2001 | DE10065938A1 Production of nitroguanidine involves reaction of guanidine nitrate with high-concentration nitric acid followed by hydrolysis of the resulting nitroguanidine nitrate with water to give dilute nitric acid as by-product |
| 12/19/2001 | EP0721449B1 Inhibitors of beta-amyloid protein production |
| 12/19/2001 | CN1076343C Creatine pyruvates and method for their production |
| 12/18/2001 | US6331640 Diaminopropionic acid derivatives |
| 12/13/2001 | WO2001094292A1 Process for the preparation of cationic surfactants |
| 12/11/2001 | US6329409 Amine derivatives and skin preparations for external use containing the same |
| 12/06/2001 | WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents |
| 12/06/2001 | WO2001092210A1 Compounds for modulating the rage receptor |
| 12/06/2001 | WO2001092207A1 Process for the production of nitrogen compounds |